DOI QR코드

DOI QR Code

Phosphorylation of tyrosine-14 on Caveolin-1 enhances lipopolysaccharide-induced inflammation in human intestinal Caco-2 cells

  • Gong Deuk Bae (Lee Gil Ya Cancer and Diabetes Institute, Department of Molecular Medicine, Gachon University) ;
  • Kyong Kim (Department of Food and Nutrition, Eulji University) ;
  • Se-Eun Jang (Department of Food and Nutrition, Eulji University) ;
  • Dong-Jae Baek (College of Pharmacy and Natural Medicine Research Institute, Mokpo National University) ;
  • Eun-Young Park (College of Pharmacy and Natural Medicine Research Institute, Mokpo National University) ;
  • Yoon Sin Oh (Department of Food and Nutrition, Eulji University)
  • Received : 2023.04.13
  • Accepted : 2023.07.13
  • Published : 2023.12.31

Abstract

Caveolin-1 (Cav-1) is the main structural component of the caveolae on the plasma membrane, which regulates various cellular processes, including cell growth, differentiation, and endocytosis. Although a recent study demonstrated that Cav-1 might be involved in diabetes-associated inflammation, its exact role in the intestine was unclear. In this study, we examined the intestinal expression of Cav-1 in diabetic conditions. We also investigated its effect on lipopolysaccharide (LPS)-induced inflammation by expressing this protein in human intestinal Caco-2 cells lacking Cav-1. We observed that increased Cav-1 levels and decreased expression of tight junction proteins affected intestinal permeability in high-fat diet-induced diabetic mice. When Caco-2 cells were treated with LPS, Cav-1 enhanced the NF-κB signaling. Moreover, LPS reduced the expression of tight junction proteins while it increased cell-cell permeability and reactive oxygen species generation in Caco-2 cells and this effect was amplified by cav-1 overexpression. LPS treatment promoted phosphorylation of tyrosine-14 (Y14) on Cav-1, and the LPS-induced NF-κB signaling was suppressed in cells expressing non-phosphorylatable Cav-1 (tyrosine-14 to phenylalanine mutant), which reduced intestinal barrier permeability. These results suggest that Cav-1 expression promotes LPS-induced inflammation in Caco-2 cells, and phosphorylation of Y14 on Cav-1 might contribute to the anti-inflammatory response in LPS-induced NF-κB signaling and cell permeability.

Keywords

Acknowledgement

This study was supported by Basic Science Research Program Grant (NRF-2021R1F1A1050949) provided by the National Research Foundation of Korea (NRF), which is funded by the Ministry of Science, ICT and Future Planning and by a grant from Eulji University in 2022.

References

  1. Guo S, Al-Sadi R, Said HM, Ma TY (2013) Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am J Pathol 182: 375-387. doi: 10.1016/j.ajpath.2012.10.014 
  2. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470-1481. doi: 10.2337/db07-1403 
  3. Park HJ, Lee SJ, Cho J, Gharbi A, Han HD, Kang TH, Kim Y, Lee Y, Park WS, Jung ID, Park YM (2018) Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. J Nat Prod 81: 1435-1443. doi: 10.1021/acs.jnatprod.8b00155 
  4. Lang CH, Silvis C, Deshpande N, Nystrom G, Frost RA (2003) Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle. Shock 19: 538-546. doi: 10.1097/01.shk.0000055237.25446.80 
  5. Park HK, Qatanani M, Briggs ER, Ahima RS, Lazar MA (2011) Inflammatory induction of human resistin causes insulin resistance in endotoxemic mice. Diabetes 60: 775-783. doi: 10.2337/db10-1416 
  6. Gonzalez-Mariscal L, Tapia R, Chamorro D (2008) Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 1778: 729-756. doi: 10.1016/j.bbamem.2007.08.018 
  7. Harhaj NS, Antonetti DA (2004) Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol 36: 1206-1237. doi: 10.1016/j.biocel.2003.08.007 
  8. Pitman RS, Blumberg RS (2000) First line of defense: the role of the intestinal epithelium as an active component of the mucosal immune system. J Gastroenterol 35: 805-814. doi: 10.1007/s005350070017 
  9. Tsukita S, Furuse M, Itoh M (2001) Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2: 285-293. doi: 10.1038/35067088 
  10. Parton RG, Simons K (2007) The multiple faces of caveolae. Nat Rev Mol Cell Biol 8: 185-194. doi: 10.1038/nrm2122 
  11. Kim YJ, Hirabayashi Y (2018) Caveolin-1 prevents palmitate-induced NF-kappaB signaling by inhibiting GPRC5B-phosphorylation. Biochem Biophys Res Commun 503: 2673-2677. doi: 10.1016/j.bbrc.2018.08.022 
  12. Jiao H, Zhang Y, Yan Z, Wang ZG, Liu G, Minshall RD, Malik AB, Hu G (2013) Caveolin-1 Tyr14 phosphorylation induces interaction with TLR4 in endothelial cells and mediates MyD88-dependent signaling and sepsis-induced lung inflammation. J Immunol 191: 6191-6199. doi: 10.4049/jimmunol.1300873 
  13. Volonte D, Galbiati F, Pestell RG, Lisanti MP (2001) Cellular Stress Induces the Tyrosine Phosphorylation of Caveolin-1 (Tyr14) via Activation of p38 Mitogen-activated Protein Kinase and c-Src kinase: Evidence for caveolae, the actin cytoskeleton, and focal adhesions as mechanical sensors of osmotic stress*. J Biol Chem 276: 8094-8103. doi: 10.1074/jbc.M009245200 
  14. Chen D-b, Li S-m, Qian X-X, Moon C, Zheng J (2005) Tyrosine Phosphorylation of Caveolin 1 by Oxidative Stress Is Reversible and Dependent on the c-src Tyrosine Kinase but Not Mitogen-Activated Protein Kinase Pathways in Placental Artery Endothelial Cells1. Biol Reprod 73: 761-772. doi: 10.1095/biolreprod.105.040881 
  15. Chidlow JH, Jr, Sessa WC (2010) Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation. Cardiovasc Res 86: 219-225. doi: 10.1093/cvr/cvq075 
  16. Bae GD, Park EY, Kim K, Jang SE, Jun HS, Oh YS (2019) Upregulation of caveolin-1 and its colocalization with cytokine receptors contributes to beta cell apoptosis. Sci Rep 9: 16785. doi: 10.1038/s41598-019-53278-z 
  17. Suzuki T, Hara H (2010) Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr Metab (Lond) 7: 19. doi: 10.1186/1743-7075-7-19 
  18. Nighot M, Rawat M, Al-Sadi R, Castillo EF, Nighot P, Ma TY (2019) Lipopolysaccharide-Induced Increase in Intestinal Permeability Is Mediated by TAK-1 Activation of IKK and MLCK/MYLK Gene. Am J Pathol 189: 797-812. doi: 10.1016/j.ajpath.2018.12.016 
  19. Rao R (2008) Oxidative stress-induced disruption of epithelial and endothelial tight junctions. Front Biosci 13: 7210-7226. doi: 10.2741/3223 
  20. Saha S, Buttari B, Panieri E, Profumo E, Saso L (2020) An Overview of Nrf2 Signaling Pathway and Its Role in Inflammation. Molecules 25: 5474. doi: 10.3390/molecules25225474 
  21. Yamamoto M, Kensler TW, Motohashi H (2018) The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis. Physiol Rev 98: 1169-1203. doi: 10.1152/physrev.00023.2017 
  22. Wang N, Zhang D, Sun G, Zhang H, You Q, Shao M, Yue Y (2015) Lipopolysaccharide-induced caveolin-1 phosphorylation-dependent increase in transcellular permeability precedes the increase in paracellular permeability. Drug Des Devel Ther 9: 4965-4977. doi: 10.2147/DDDT.S77646 
  23. Moreira AP, Texeira TF, Ferreira AB, Peluzio Mdo C, Alfenas Rde C (2012) Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 108: 801-809. doi: 10.1017/S0007114512001213 
  24. Catalan V, Gomez-Ambrosi J, Rodriguez A, Silva C, Rotellar F, Gil MJ, Cienfuegos JA, Salvador J, Fruhbeck G (2008) Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation. Clin Endocrinol 68: 213-219. doi: 10.1111/j.1365-2265.2007.03021.x 
  25. Uyy E, Antohe F, Ivan L, Haraba R, Radu DL, Simionescu M (2010) Upregulation of caveolin-1 expression is associated with structural modifications of endothelial cells in diabetic lung. Microvasc Res 79: 154-159. doi: 10.1016/j.mvr.2009.11.008 
  26. Wehinger S, Ortiz R, Diaz MI, Aguirre A, Valenzuela M, Llanos P, Mc Master C, Leyton L, Quest AFG (2015) Phosphorylation of caveolin-1 on tyrosine-14 induced by ROS enhances palmitate-induced death of beta-pancreatic cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1852: 693-708. doi: 10.1016/j.bbadis.2014.12.021 
  27. Weiss CR, Guan Q, Ma Y, Qing G, Bernstein CN, Warrington RJ, Peng Z (2015) The potential protective role of caveolin-1 in intestinal inflammation in TNBS-induced murine colitis. PLoS One 10: e0119004. doi: 10.1371/journal.pone.0119004 
  28. Leal RF, Milanski M, Ayrizono Mde L, Coope A, Rodrigues VS, Portovedo M, Oliveira LM, Fagundes JJ, Coy CS, Velloso LA (2013) Toll-like receptor 4, F4/80 and pro-inflammatory cytokines in intestinal and mesenteric fat tissue of Crohn's disease. Int J Clin Exp Med 6: 98-104 
  29. Garrean S, Gao XP, Brovkovych V, Shimizu J, Zhao YY, Vogel SM, Malik AB (2006) Caveolin-1 regulates NF-kappaB activation and lung inflammatory response to sepsis induced by lipopolysaccharide. J Immunol 177: 4853-4860. doi: 10.4049/jimmunol.177.7.4853 
  30. Nusrat A, Parkos CA, Verkade P, Foley CS, Liang TW, Innis-Whitehouse W, Eastburn KK, Madara JL (2000) Tight junctions are membrane microdomains. J Cell Sci 113 (Pt 10): 1771-1781. doi: 10.1242/jcs.113.10.1771 
  31. Ares G, Buonpane C, Sincavage J, Yuan C, Wood DR, Hunter CJ (2019) Caveolin 1 is Associated with Upregulated Claudin 2 in Necrotizing Enterocolitis. Sci Rep 9: 4982. doi: 10.1038/s41598-019-41442-4 
  32. Nag S, Venugopalan R, Stewart DJ (2007) Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown. Acta Neuropathol 114: 459-469. doi: 10.1007/s00401-007-0274-x 
  33. Zhong Y, Smart EJ, Weksler B, Couraud P-O, Hennig B, Toborek M (2008) Caveolin-1 Regulates Human Immunodeficiency Virus-1 Tat-Induced Alterations of Tight Junction Protein Expression via Modulation of the Ras Signaling. J Neurosci 28: 7788-7796. doi: 10.1523/jneurosci.0061-08.2008 
  34. Aviello G, Knaus U (2017) ROS in gastrointestinal inflammation: Rescue Or Sabotage? Br. J Pharmacol 174: 1704-1718. doi: 10.1111/bph.13428 
  35. Hsu H-Y, Wen M-H (2002) Lipopolysaccharide-mediated Reactive Oxygen Species and Signal Transduction in the Regulation of Interleukin-1 Gene Expression*. J Biol Chem 277: 22131-22139. doi: 10.1074/jbc.M111883200 
  36. Zou H, Stoppani E, Volonte D, Galbiati F (2011) Caveolin-1, cellular senescence and age-related diseases. Mech Ageing Dev 132: 533-542. doi: 10.1016/j.mad.2011.11.001 
  37. Shajahan AN, Dobbin ZC, Hickman FE, Dakshanamurthy S, Clarke R (2012) Tyrosine-phosphorylated Caveolin-1 (Tyr-14) Increases Sensitivity to Paclitaxel by Inhibiting BCL2 and BCLxL Proteins via c-Jun N-terminal Kinase (JNK)*. J Biol Chem 287: 17682-17692. doi: 10.1074/jbc.M111.304022 
  38. Parton RG, del Pozo MA (2013) Caveolae as plasma membrane sensors, protectors and organizers. Nat Rev Mol Cell Biol 14: 98-112. doi: 10.1038/nrm3512 
  39. Sanguinetti AR, Mastick CC (2003) c-Abl is required for oxidative stress-induced phosphorylation of caveolin-1 on tyrosine 14. Cell Signal 15: 289-298. doi: 10.1016/S0898-6568(02)00090-6